Functional outcomes of ischemic stroke patients aged over 80 years treated with acute revascularization therapy according to pre-morbid disability: a PARADISE study.

Ségolène Ruel, Laura Baptiste, Gauthier Duloquin, Yannick Béjot
Author Information
  1. Ségolène Ruel: Dijon Stroke Registry, Department of Neurology, University Hospital of Dijon, University of Burgundy, Dijon, France.
  2. Laura Baptiste: Dijon Stroke Registry, Department of Neurology, University Hospital of Dijon, University of Burgundy, Dijon, France.
  3. Gauthier Duloquin: Dijon Stroke Registry, Department of Neurology, University Hospital of Dijon, University of Burgundy, Dijon, France.
  4. Yannick Béjot: Dijon Stroke Registry, Department of Neurology, University Hospital of Dijon, University of Burgundy, Dijon, France.

Abstract

Introduction: Aging population leads to changes in the profile of patients with acute ischemic stroke (IS), and older adults were largely excluded from randomized clinical trials of acute revascularization therapy. This study aimed to assess functional outcomes of treated IS patients > 80 years old according to prior disability and identify associated factors.
Methods: Consecutively older patients with acute IS treated with either IV thrombolysis and/or mechanical thrombectomy were enrolled between 2016 and 2019. Pre-morbid disability was assessed using the modified Rankin Scale (mRS) score, and patients were classified as being independent (mRS score, 0-2) or having pre-existing disability (mRS score, 3-5). A multivariable logistic regression analysis was performed to assess factors associated with a poor functional outcome (mRS score > 3) at 3 and 12 months in each group of patients.
Results: Among 300 included patients (mean age: 86.3 ± 4.6 years, 63% women, median NIHSS score: 14, IQR: 8-19), 100 had a pre-existing disability. In patients with a pre-morbid mRS score of 0-2, 51% had mRS >3 including 33% of deaths at 3 months. At 12 months, 50% had a poor outcome including 39% of deaths. In patients with a pre-morbid mRS score of 3-5, 71% had a poor outcome at 3 months including 43% of deaths, and at 12 months, 76% had mRS >3 including 52% of deaths. In multivariable models, the NIHSS score at 24 h was independently associated with poor outcomes at 3 and 12 months in both patients with (OR = 1.32; 95% CI: 1.16-1.51, < 0.001 for 12 months outcome) or without (OR = 1.31; 95% CI: 1.19-1.44, < 0.001 for 12 months outcome) pre-morbid disability.
Conclusion: Although a large proportion of older patients with a pre-existing disability had a poor functional outcome, they did not differ from their non-impaired counterparts regarding prognostic factors. This means that there were no factors in our study that would help clinicians identify patients at risk of poor functional outcomes after revascularization therapy among those with prior disability. Further studies are needed to better understand the post-stroke trajectory of older IS patients with a pre-morbid disability.

Keywords

References

  1. Brain Behav. 2019 Jun;9(6):e01300 [PMID: 31066194]
  2. Neurology. 2021 Nov 16;97(20 Suppl 2):S6-S16 [PMID: 34785599]
  3. Eur Stroke J. 2021 Mar;6(1):I-LXII [PMID: 33817340]
  4. Neurology. 2020 Feb 18;94(7):306-310 [PMID: 31969466]
  5. Stroke. 2018 Oct;49(10):2430-2436 [PMID: 30355105]
  6. Stroke. 2016 Sep;47(9):2373-9 [PMID: 27507856]
  7. Age Ageing. 2007 May;36(3):247-55 [PMID: 17360793]
  8. Stroke. 2022 May;53(5):e204-e217 [PMID: 35343235]
  9. Stroke. 1997 Nov;28(11):2109-18 [PMID: 9368550]
  10. Neuroepidemiology. 2019;52(1-2):78-85 [PMID: 30602168]
  11. Age Ageing. 2021 May 5;50(3):898-905 [PMID: 33009911]
  12. J Neurointerv Surg. 2022 Aug;14(8):747-751 [PMID: 34475251]
  13. Interv Neurol. 2016 Mar;4(3-4):120-9 [PMID: 27051408]
  14. Int J Stroke. 2022 Dec;17(10):1085-1092 [PMID: 35225745]
  15. Neuroepidemiology. 2020;54(6):490-497 [PMID: 31593950]
  16. Stroke. 2020 Jun;51(6):1667-1673 [PMID: 32397931]
  17. Dement Geriatr Cogn Disord. 2022;51(2):101-109 [PMID: 35405675]
  18. Cerebrovasc Dis. 2021;50(1):68-77 [PMID: 33321502]
  19. Lancet Neurol. 2006 Jul;5(7):603-12 [PMID: 16781990]
  20. J Neurointerv Surg. 2020 Mar;12(3):266-270 [PMID: 31350369]
  21. Stroke. 2020 Jan;51(1):282-290 [PMID: 31795895]
  22. Stroke. 2014 Mar;45(3):770-5 [PMID: 24496395]
  23. AJNR Am J Neuroradiol. 2018 May;39(5):887-891 [PMID: 29567654]
  24. Lancet. 2016 Apr 23;387(10029):1723-31 [PMID: 26898852]
  25. J Stroke Cerebrovasc Dis. 2022 Oct;31(10):106699 [PMID: 36054973]
  26. Front Neurol. 2022 Apr 28;13:880046 [PMID: 35572918]
  27. Stroke. 2016 Feb;47(2):450-6 [PMID: 26797662]
  28. Stroke. 2019 Aug;50(8):2037-2043 [PMID: 33755497]
  29. Presse Med. 2016 Dec;45(12 Pt 2):e391-e398 [PMID: 27816343]

Word Cloud

Created with Highcharts 10.0.0patientsdisabilitymRSmonthsscoreoutcomepoor312olderpre-morbidacuteISfunctionaloutcomesfactorsincludingdeaths1ischemicstrokerevascularizationtherapystudytreatedyearsassociatedpre-existingassess>80accordingprioridentifythrombolysismechanicalthrombectomy0-23-5multivariableNIHSS>3OR=95%CI:<0001Introduction:AgingpopulationleadschangesprofileadultslargelyexcludedrandomizedclinicaltrialsaimedoldMethods:ConsecutivelyeitherIVand/orenrolled20162019Pre-morbidassessedusingmodifiedRankinScaleclassifiedindependentlogisticregressionanalysisperformedgroupResults:Among300includedmeanage:86±4663%womenmedianscore:14IQR:8-1910051%33%50%39%71%43%76%52%models24hindependently3216-151without3119-144Conclusion:Althoughlargeproportiondiffernon-impairedcounterpartsregardingprognosticmeanshelpcliniciansriskamongstudiesneededbetterunderstandpost-stroketrajectoryFunctionalageddisability:PARADISE

Similar Articles

Cited By